307 related articles for article (PubMed ID: 15979079)
21. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
Enomoto Y; Suzuki Y; Hozumi H; Mori K; Kono M; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suzuki D; Ogawa N; Nakashima R; Mimori T; Iwashita T; Suda T
Arthritis Res Ther; 2017 Jan; 19(1):9. PubMed ID: 28103926
[TBL] [Abstract][Full Text] [Related]
22. Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Rahman SH; Menon KV; Holmfield JH; McMahon MJ; Guillou JP
Ann Surg; 2007 Feb; 245(2):282-9. PubMed ID: 17245183
[TBL] [Abstract][Full Text] [Related]
23. Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications.
Tantawy AA; Adly AA; Ismail EA
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):640-8. PubMed ID: 22885767
[TBL] [Abstract][Full Text] [Related]
24. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
Laursen TL; Wong GL; Kazankov K; Sandahl T; Møller HJ; Hamilton-Dutoit S; George J; Chan HL; Grønbaek H
J Gastroenterol Hepatol; 2018 Feb; 33(2):484-491. PubMed ID: 28618015
[TBL] [Abstract][Full Text] [Related]
25. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
26. Preterm delivery predicted by soluble CD163 and CRP in women with symptoms of preterm delivery.
Vogel I; Grove J; Thorsen P; Moestrup SK; Uldbjerg N; Møller HJ
BJOG; 2005 Jun; 112(6):737-42. PubMed ID: 15924529
[TBL] [Abstract][Full Text] [Related]
27. Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
Grønbaek H; Sandahl TD; Mortensen C; Vilstrup H; Møller HJ; Møller S
Aliment Pharmacol Ther; 2012 Jul; 36(2):173-80. PubMed ID: 22591184
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
Dultz G; Gerber L; Farnik H; Berger A; Vermehren J; Pleli T; Zeuzem S; Piiper A; Kronenberger B; Waidmann O
J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653
[TBL] [Abstract][Full Text] [Related]
29. Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
Kazankov K; Rode A; Simonsen K; Villadsen GE; Nicoll A; Møller HJ; Lim L; Angus P; Kronborg I; Arachchi N; Gorelik A; Liew D; Vilstrup H; Frystyk J; Grønbæk H
Scand J Clin Lab Invest; 2016; 76(1):64-73. PubMed ID: 26549495
[TBL] [Abstract][Full Text] [Related]
30. Increased serum levels of macrophage activation marker sCD163 in Dengue patients.
S S SG; Pillai AB; Ramachandrappa VS; T K; Dhodapkar R; Kah J; Rajendiran S
J Clin Virol; 2017 Jan; 86():62-67. PubMed ID: 27960133
[TBL] [Abstract][Full Text] [Related]
31. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
32. Soluble CD163.
Møller HJ
Scand J Clin Lab Invest; 2012 Feb; 72(1):1-13. PubMed ID: 22060747
[TBL] [Abstract][Full Text] [Related]
33. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome.
Schaer DJ; Schleiffenbaum B; Kurrer M; Imhof A; Bächli E; Fehr J; Moller HJ; Moestrup SK; Schaffner A
Eur J Haematol; 2005 Jan; 74(1):6-10. PubMed ID: 15613100
[TBL] [Abstract][Full Text] [Related]
34. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
Bielecki M; Kowal K; Lapinska A; Chyczewski L; Kowal-Bielecka O
Adv Med Sci; 2013; 58(1):126-33. PubMed ID: 23640944
[TBL] [Abstract][Full Text] [Related]
35. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
Gaïni S; Pedersen SS; Koldkaer OG; Pedersen C; Moestrup SK; Møller HJ
Clin Exp Immunol; 2008 Mar; 151(3):423-31. PubMed ID: 18190604
[TBL] [Abstract][Full Text] [Related]
36. Soluble CD163: a marker molecule for monocyte/macrophage activity in disease.
Møller HJ; Aerts H; Grønbaek H; Peterslund NA; Hyltoft Petersen P; Hornung N; Rejnmark L; Jabbarpour E; Moestrup SK
Scand J Clin Lab Invest Suppl; 2002; 237():29-33. PubMed ID: 12570164
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
Waidmann O; Köberle V; Bettinger D; Trojan J; Zeuzem S; Schultheiß M; Kronenberger B; Piiper A
J Hepatol; 2013 Oct; 59(4):769-79. PubMed ID: 23792028
[TBL] [Abstract][Full Text] [Related]
38. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
[TBL] [Abstract][Full Text] [Related]
39. Levels of soluble CD163 and severity of malaria in children in Ghana.
Kusi KA; Gyan BA; Goka BQ; Dodoo D; Obeng-Adjei G; Troye-Blomberg M; Akanmori BD; Adjimani JP
Clin Vaccine Immunol; 2008 Sep; 15(9):1456-60. PubMed ID: 18632918
[TBL] [Abstract][Full Text] [Related]
40. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Ishida C; Tanaka S; Morishima T; Ichiyama T
Brain Dev; 2013 Aug; 35(7):626-9. PubMed ID: 23149357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
